Teicoplanin derivatives block spike protein mediated viral entry as pan-SARS-CoV-2 inhibitors

The rapid emergence of highly transmissible SARS-CoV-2 variants poses serious threat to the efficacy of vaccines and neutralizing antibodies. Thus, there is an urgent need to develop new and effective inhibitors against SARS-CoV-2 and future outbreaks. Here, we have identified a series of glycopepti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ling, Li, Yali, Shi, Ting, Zhu, Zhiling, zhao, Jianyuan, Xie, Yongli, Wen, Jiajia, Guo, Saisai, Wang, Jing, Ding, Jiwei, Liang, Chen, Shan, Guangzhi, Li, Quanjie, Ge, Mei, Cen, Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808420/
https://www.ncbi.nlm.nih.gov/pubmed/36916436
http://dx.doi.org/10.1016/j.biopha.2023.114213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808420/
https://www.ncbi.nlm.nih.gov/pubmed/36916436
http://dx.doi.org/10.1016/j.biopha.2023.114213

Ejemplares similares